Your Article Summary
A review of minimal change disease in adults
British Journal of Renal Medicine, 07/02/09
Minimal change disease (MCD) is the cause of the nephrotic syndrome in 10–15% of adults who have the condition. MCD is characterised by no discernable histological abnormality on light microscopy. Ultrastructural examination by electron microscopy reveals fusion of the podocyte foot processes, although this is not pathognomonic of the disease.
Related Articles
A case of minimal change disease in a Fabry patient
Pediatric Nephrology, 11/04/09
Relevance Score: 82%
Occupational health epidemiology in the Nordic countries - status and trends
Scandinavian Journal of Work, Environment & Health, 11/16/09
Relevance Score: 78%
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09
Relevance Score: 78%
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial
Gut, 10/22/09
Relevance Score: 78%
Serum Immunoglobulin E Can Predict Minimal Change Disease Before Renal Biopsy
The American Journal of the Medical Sciences, 10/14/09
Relevance Score: 78%
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women
BJU International, 11/30/09
EAU Guidelines on Chronic Pelvic Pain
European Urology, 11/30/09
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
European Urology, 11/30/09

See Latest Articles